| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $18.0M | -45.1% |
| SG&A Expense | $8.7M | -67.1% |
| Operating Income | -$26.7M | +54.2% |
| Income Tax | $0 | +100.0% |
| Net Income | -$18.2M | +74.3% |
| EPS (Basic) | -$2.46 | +84.2% |
| EPS (Diluted) | -$3.26 | +79.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.7M | -45.3% |
| Short-term Investments | $10.1M | — |
| Current Assets | $31.5M | -28.0% |
| Total Assets | $32.1M | -26.8% |
| Current Liabilities | $11.0M | +178.0% |
| Total Liabilities | $11.1M | -77.0% |
| Stockholders' Equity | $20.9M | +556.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.5M | +61.4% |
| Investing Cash Flow | -$10.1M | -120.7% |
| Financing Cash Flow | $22.7M | +729.9% |